Form 4: Cassava Sciences CEO Buys Shares
Insider Transaction (Form 4)
Richard Barry, President & CEO and a Director of Cassava Sciences Inc, purchased 44,851 shares of common stock on November 18, 2026 for $0.52 per share.
Summary
- Open-market purchase: acquired 44,851 Common Stock at $0.52 ($23,323) on November 18, 2026; holds 1,955,947 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $23,323, committing personal capital to the stock.
Insider Transactions
Richard Barry — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-18 | Open-market purchase | Common Stock | 44,851 | $1 | $23.3K | 1,955,947 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-18 | Open-market purchase (44,851 shares) |
Keywords
insider transaction, Form 4, FLNA, FILANA THERAPEUTICS, INC., bullish, Richard Barry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.